Fidelity Investments’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.36M Sell
181,626
-80,384
-31% -$1.05M ﹤0.01% 2434
2025
Q1
$2.77M Sell
262,010
-186,801
-42% -$1.98M ﹤0.01% 2344
2024
Q4
$7.62M Buy
448,811
+5,803
+1% +$98.5K ﹤0.01% 2028
2024
Q3
$10.3M Sell
443,008
-112,516
-20% -$2.61M ﹤0.01% 1914
2024
Q2
$13.5M Sell
555,524
-66,334
-11% -$1.62M ﹤0.01% 1779
2024
Q1
$21M Sell
621,858
-242,500
-28% -$8.19M ﹤0.01% 1634
2023
Q4
$27.3M Sell
864,358
-75,923
-8% -$2.39M ﹤0.01% 1508
2023
Q3
$24M Buy
940,281
+74,081
+9% +$1.89M ﹤0.01% 1517
2023
Q2
$24.8M Buy
866,200
+37,808
+5% +$1.08M ﹤0.01% 1555
2023
Q1
$19.9M Sell
828,392
-81,851
-9% -$1.96M ﹤0.01% 1610
2022
Q4
$15.4M Sell
910,243
-44,082
-5% -$748K ﹤0.01% 1720
2022
Q3
$14.1M Buy
954,325
+33,568
+4% +$497K ﹤0.01% 1750
2022
Q2
$14.5M Sell
920,757
-39
-0% -$614 ﹤0.01% 1785
2022
Q1
$24.8M Buy
920,796
+272
+0% +$7.33K ﹤0.01% 1693
2021
Q4
$34.1M Sell
920,524
-152,453
-14% -$5.64M ﹤0.01% 1574
2021
Q3
$51.3M Buy
1,072,977
+342,687
+47% +$16.4M ﹤0.01% 1400
2021
Q2
$24.7M Hold
730,290
﹤0.01% 1756
2021
Q1
$30.2M Hold
730,290
﹤0.01% 1617
2020
Q4
$31.7M Sell
730,290
-39,710
-5% -$1.72M ﹤0.01% 1502
2020
Q3
$33M Buy
770,000
+95,000
+14% +$4.08M ﹤0.01% 1357
2020
Q2
$31.6M Buy
675,000
+275,000
+69% +$12.9M ﹤0.01% 1357
2020
Q1
$5.44M Hold
400,000
﹤0.01% 1913
2019
Q4
$4.35M Hold
400,000
﹤0.01% 2084
2019
Q3
$4.11M Buy
+400,000
New +$4.11M ﹤0.01% 2102